DocWire: African American men less likely to use targeted prostate cancer detection method

Study shows that African American men receive MRI-ultrasound biopsies less than white men

The findings of a new study published in the journal Prostate Cancer show that African American males are less likely to use a more targeted biopsy option for prostate cancer detection.

“Black men have a significantly higher incidence and are up to three times more likely to die of prostate cancer than white men,” says Dr. Abhinav Sidana, director of urologic oncology and assistant professor in the Division of Urology at the UC College of Medicine, a UC Health urologist and corresponding author on this study. “MRI-ultrasound biopsy has emerged as a promising option for the detection of prostate cancer. In this study, we wanted to identify differences in use of MRI-ultrasound biopsy between black and white men with possible prostate cancer.”

Read the full story.

Read the UC news release. 

Featured photo by Colleen Kelley/UC Creative Services

Related Stories

2

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.